Phosphatidylserine IgG, IgM, & IgA Autoabs
Test Mnemonic
PHOGMA
CPT Codes
- 86148 - QTY (3)
Includes
- Phosphatidylserine IgA
- Phosphatidylserine IgG
- Phosphatidylserine IgM
Performing Laboratory
ARUP
Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.5 mL | Serum | SST (Gold) | Refrigerated |
Alternate Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.5 mL | Serum | No additive (Red) | Refrigerated |
Minimum Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.25 mL |
Stability
| Environmental Condition | Description |
|---|---|
| Ambient | After separation from cells: 48 hours |
| Refrigerated | After separation from cells: 2 weeks |
| Frozen | After separation from cells: 1 month (Avoid repeated freeze/thaw cycles) |
Days Performed
Sun, Tue, Wed, Fri, Sat
Turnaround Time
2 - 5 days
Methodology
| Name | Description |
|---|---|
| Enzyme-Linked Immunosorbent Assay (ELISA) |
Reference Range
| Phosphatidylserine IgA | |||||
|---|---|---|---|---|---|
| Sex | Age From | Age To | Type | Range | Range Unit |
| < 20 APS (IgA antiphosphatidylserine units) | |||||
| Phosphatidylserine IgG | |||||
| Sex | Age From | Age To | Type | Range | Range Unit |
| < 16 GPS (IgG antiphosphatidylserine units) | |||||
| Phosphatidylserine IgM | |||||
| Sex | Age From | Age To | Type | Range | Range Unit |
| < 22 MPS (IgM antiphosphatidylserine units) |
Special Info
Contaminated, heat-inactivated, hemolyzed, or severely lipemic specimens will be rejected. This test is New York DOH approved.
Clinical Info
Phosphatidylserine autoantibodies are associated with SLE, lupus-like diseases and the primary antiphospholipid syndrome. Clinical problems are generally related to arterial and deep venous thromboses, recurrent spontaneous abortion, neurological and cardiological manifestations and thrombocytopenia.